🇺🇸 FDA
Patent

US 11331385

Methods of preparing anti-human papillomavirus antigen T cells

granted A61KA61K2039/5158A61K2039/572

Quick answer

US patent 11331385 (Methods of preparing anti-human papillomavirus antigen T cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/5158, A61K2039/572, A61K2039/585, A61K35/17